These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1477459

  • 1. Lipoprotein(a) levels in the nephrotic syndrome.
    Kanno H, Saito E, Fujioka T, Yasugi T.
    Intern Med; 1992 Aug; 31(8):1004-8. PubMed ID: 1477459
    [Abstract] [Full Text] [Related]

  • 2. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T, Kitoh C, Haba T, Hirai J, Wakasugi T, Saga T, Yamazaki Y, Mabuchi H.
    Jpn J Med; 1991 Aug; 30(1):21-5. PubMed ID: 1830908
    [Abstract] [Full Text] [Related]

  • 3. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
    Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J.
    Am J Kidney Dis; 1993 Dec; 22(6):808-13. PubMed ID: 8250027
    [Abstract] [Full Text] [Related]

  • 4. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Jul 15; 66(1):348-54. PubMed ID: 15200443
    [Abstract] [Full Text] [Related]

  • 6. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 15; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in serum lipoprotein(a) levels in children with corticosensitive nephrotic syndrome.
    Garnotel R, Roussel B, Pennaforte F, Randoux A, Gillery P.
    Pediatr Nephrol; 1996 Dec 15; 10(6):699-701. PubMed ID: 8971882
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.
    Clin Chem; 1995 Jun 15; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic syndrome.
    Hong SY, Yang DH.
    Nephron; 1995 Jun 15; 69(2):125-30. PubMed ID: 7723892
    [Abstract] [Full Text] [Related]

  • 14. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M.
    N Engl J Med; 1990 Aug 30; 323(9):579-84. PubMed ID: 2381443
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein(a) in nephrotic syndrome.
    Stenvinkel P, Berglund L, Heimbürger O, Pettersson E, Alvestrand A.
    Kidney Int; 1993 Nov 30; 44(5):1116-23. PubMed ID: 8264144
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
    Nakahara C, Kobayashi K, Hamaguchi H, Kanemoto K, Kashiwagi R, Matsui A.
    Pediatr Nephrol; 1999 Oct 30; 13(8):657-61. PubMed ID: 10502122
    [Abstract] [Full Text] [Related]

  • 19. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP.
    Nephrol Dial Transplant; 1994 Oct 30; 9(3):244-50. PubMed ID: 8052429
    [Abstract] [Full Text] [Related]

  • 20. Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?
    Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF.
    Clin Chim Acta; 1981 Dec 24; 117(3):317-23. PubMed ID: 7318185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.